Evidence map›Paper›PMID 40681490›Full record

ArticleNature communications2025

Diastereoselective synthesis of multi-substituted cyclobutanes via catalyst-controlled regiodivergent hydrophosphination of acyl bicyclobutanes.

Heng-Xian He, Feng Wu, Kun-Ju Wang, Lei Wang, Jian-Jun Feng

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Heng-Xian He *State Key Laboratory of Chemo and Biosensing, Advanced Catalytic Engineering Research Center of the Ministry of Education, College of Chemistry and Chemical Engineering, Hunan University, Changsha, PR China.
Feng Wu *State Key Laboratory of Chemo and Biosensing, Advanced Catalytic Engineering Research Center of the Ministry of Education, College of Chemistry and Chemical Engineering, Hunan University, Changsha, PR China.ORCID http://orcid.org/0000-0003-1918-1596
Kun-Ju WangState Key Laboratory of Chemo and Biosensing, Advanced Catalytic Engineering Research Center of the Ministry of Education, College of Chemistry and Chemical Engineering, Hunan University, Changsha, PR China.
Lei WangSchool of Chemistry & Chemical Engineering, Yangzhou University, Yangzhou, PR China.ORCID http://orcid.org/0000-0002-8792-0234
Jian-Jun FengState Key Laboratory of Chemo and Biosensing, Advanced Catalytic Engineering Research Center of the Ministry of Education, College of Chemistry and Chemical Engineering, Hunan University, Changsha, PR China. jianjunfeng@hnu.edu.cn.ORCID http://orcid.org/0000-0002-6094-3268

Funding

National Natural Science Foundation of China (National Science Foundation of China) 22471068
6 · The paper itself

Abstract

Although ring-opening reactions of bicyclo[1.1.0]butanes (BCBs) provide a reliable platform for synthesizing functionalized cyclobutanes, current methods frequently encounter challenges such as poor diastereoselectivity, regioselectivity issues, and a lack of α- and β'-selective transformations. Herein, we report a catalyst-controlled, regiodivergent α- and β'-selective hydrophosphination of acyl BCBs, which expands the chemical space of tertiary phosphines with multi-substituted cyclobutane backbones derived from identical starting materials. Utilizing a Cu(I) catalytic system, we achieve an α-selective nucleophilic addition to 1,3-disubstituted BCBs. This reaction exhibits a broad substrate scope under mild conditions, yielding valuable 1,1,3-functionalized cyclobutanes predominantly as single diastereoisomers. In contrast, the unusual β'-selective pathway facilitated by a Cu(II) catalytic system produces 1,2,3-trisubstituted variants with up to >20:1 d.r. The developed method holds promise for accessing structurally diverse cyclobutanes with potential applications in medicinal chemistry and the design of organophosphorus catalysts.

Identifiers

PMID40681490
PMCPMC12274483

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.